aTyr Pharma, Inc. (NASDAQ:ATYR) Q4 2024 Earnings Call Transcript March 13, 2025
aTyr Pharma, Inc. beats earnings expectations. Reported EPS is $-0.18, expectations were $-0.23.
Operator: Good afternoon, ladies and gentlemen, and welcome to the aTyr Pharma Fourth Quarter and Full Year 2024 Conference Call. At this time, all participants are in a listen-only mode. Later, we will conduct a question-and-answer session, and instructions will be given at that time. As a reminder, this conference...
